RLYB
RLYB
NASDAQ · Biotechnology

Rallybio Corp

$17.05
+0.43 (+2.59%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -18.9% upside
Low Target $9.36
Average Target $13.83
High Target $17.78
Current Price $17.05
Current
$17.05
Target
$13.83
$9.36 $13.83 avg $17.78
Scenario Analysis
Bear Case
$9.36
-45.1%
Low target
Base Case
$13.83
-18.9%
Avg target
Bull Case
$17.78
+4.3%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$17.57
-3.0% from high
52-Week Low
$3.67
+364.6% from low
Target vs 52W High
$13.83
-21.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%